Letter: the clinical course of Crohn's disease-the Sicilian experience. Authors' reply

Johan Burisch^{1

2}, Ebbe Langholz^{3

4}, Pia Munkholm⁵

Affiliations

¹ Gastrounit, Medical Division, Hvidovre Hospital, University of Copenhagen, Hvidovre, Denmark.
² Copenhagen Center for Inflammatory Bowel Disease in Children, Adolescents, and Adults, Hvidovre Hospital, University of Copenhagen, Hvidovre, Denmark.
³ Department of Gastroenterology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.
⁴ Institute for Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
⁵ Department of Gastroenterology, North Zealand Hospital, University of Copenhagen, Hillerød, Denmark.

Comment

Johan Burisch et al. Aliment Pharmacol Ther. 2022 May.

. 2022 May;55(9):1239-1240.

doi: 10.1111/apt.16898.

Johan Burisch^{1

2}, Ebbe Langholz^{3

4}, Pia Munkholm⁵

¹ Gastrounit, Medical Division, Hvidovre Hospital, University of Copenhagen, Hvidovre, Denmark.
² Copenhagen Center for Inflammatory Bowel Disease in Children, Adolescents, and Adults, Hvidovre Hospital, University of Copenhagen, Hvidovre, Denmark.
³ Department of Gastroenterology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.
⁴ Institute for Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
⁵ Department of Gastroenterology, North Zealand Hospital, University of Copenhagen, Hillerød, Denmark.

No abstract available

Comment on

The clinical course of Crohn's disease in a Danish population-based inception cohort with more than 50 years of follow-up, 1962-2017.
Burisch J, Lophaven S, Langholz E, Munkholm P. Burisch J, et al. Aliment Pharmacol Ther. 2022 Jan;55(1):73-82. doi: 10.1111/apt.16615. Epub 2021 Sep 20. Aliment Pharmacol Ther. 2022. PMID: 34543457
Letter: the clinical course of Crohn's disease-the Sicilian experience.
Demarzo MG, Viola A, Picci A, Fries W. Demarzo MG, et al. Aliment Pharmacol Ther. 2022 May;55(9):1237-1238. doi: 10.1111/apt.16873. Aliment Pharmacol Ther. 2022. PMID: 35429024 No abstract available.

1. Burisch J, Lophaven S, Langholz E, Munkholm P. The clinical course of Crohn’s disease in a Danish population-based inception cohort with more than 50 years of follow-up, 1962-2017. Aliment Pharmacol Ther. 2022;55:73-82.
1. Dermazo M, Viola A, Picci A, et al. Letter: the clinical course of Crohn’s disease - the Sicilian experience. Aliment Pharmacol Ther 2022;55:1237-1238.
1. Vind I, Riis L, Jess T, Knudsen E, Pedersen N, Elkjaer M, et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and county, 2003-2005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol. 2006;101:1274-82.
1. Wolters FL, Joling C, Russel MG, Sijbrandij J, de Bruin M, Odes S, et al. Treatment inferred disease severity in Crohn’s disease: evidence for a European gradient of disease course. Scand J Gastroenterol. 2007;42:333-44.
1. Burisch J, Lophaven S, Munkholm P, Langholz E. Surgery, cancer and mortality among patients with ulcerative colitis diagnosed 1962-1987 and followed until 2017 in a Danish population-based inception cohort. Aliment Pharmacol Ther. 2022;55:339-49.